Madaswamy S Muthu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 21

Top Topics

Oxide Nanoparticles

Magnetic Resonance Imaging

Epidermal Growth Factor Receptor

Top Venues

Molecular pharmaceutics

Nanomedicine (London, England)

ACS applied bio materials

Therapeutic delivery

This page only lists publications with an associated author ORCID identifier.

Publications

Nidhi Verma, Aseem Setia, Abhishesh Kumar Mehata, Nandini Randhave, Paresh Badgujar, Ankit Kumar Malik, Madaswamy S Muthu
Recent Advancement of Indocyanine Green Based Nanotheranostics for Imaging and Therapy of Coronary Atherosclerosis. Molecular pharmaceutics (2024)
Piyush Dhamija, Abhishesh Kumar Mehata, Rupen Tamang, Jyoti Bonlawar, null Vaishali, Ankit Kumar Malik, Aseem Setia, Shailendra Kumar, Ranadheer Reddy Challa, Biplob Koch, Madaswamy S Muthu
Redox-Sensitive Poly(lactic- co -glycolic acid) Nanoparticles of Palbociclib: Development, Ultrasound/Photoacoustic Imaging, and Smart Breast Cancer Therapy. Molecular pharmaceutics 21 (6) (2024)
Abhishesh Kumar Mehata, Jyoti Bonlawar, Rupen Tamang, Ankit Kumar Malik, Aseem Setia, Shailendra Kumar, Ranadheer Reddy Challa, Bhaskar Vallamkonda, Biplob Koch, Madaswamy S Muthu
PLGA Nanoplatform for the Hypoxic Tumor Delivery: Folate Targeting, Therapy, and Ultrasound/Photoacoustic Imaging. ACS applied bio materials (2024)
Piyush Dhamija, Abhishesh Kumar Mehata, Rupen Tamang, Jyoti Bonlawar, null Vaishali, Ankit Kumar Malik, Aseem Setia, Shailendra Kumar, Ranadheer Reddy Challa, Biplob Koch, Madaswamy S Muthu
Redox-Sensitive Poly(lactic- co -glycolic acid) Nanoparticles of Palbociclib: Development, Ultrasound/Photoacoustic Imaging, and Smart Breast Cancer Therapy. Molecular pharmaceutics (2024)
Abhishesh Kumar Mehata, Jyoti Bonlawar, Rupen Tamang, Ankit Kumar Malik, Aseem Setia, Shailendra Kumar, Ranadheer Reddy Challa, Bhaskar Vallamkonda, Biplob Koch, Madaswamy S Muthu
PLGA Nanoplatform for the Hypoxic Tumor Delivery: Folate Targeting, Therapy, and Ultrasound/Photoacoustic Imaging. ACS applied bio materials 7 (8) (2024)
Abhishesh Kumar Mehata, Virendra Singh, null Vikas, Nitesh Singh, Abhijit Mandal, Debabrata Dash, Biplob Koch, Madaswamy S Muthu
Chitosan- g -estrone Nanoparticles of Palbociclib Vanished Hypoxic Breast Tumor after Targeted Delivery: Development and Ultrasound/Photoacoustic Imaging. ACS applied materials & interfaces (2023)
Vishnu Priya, null Samridhi, Nitesh Singh, Debabrata Dash, Madaswamy S Muthu
Nattokinase Encapsulated Nanomedicine for Targeted Thrombolysis: Development, Improved in Vivo Thrombolytic Effects, and Ultrasound/Photoacoustic Imaging. Molecular pharmaceutics 21 (1) (2023)
Abhishesh Kumar Mehata, null Vikas, Matte Kasi Viswanadh, Madaswamy S Muthu
Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation. Nanomedicine (London, England) (2023)
Vishnu Priya, null Samridhi, Nitesh Singh, Debabrata Dash, Madaswamy S Muthu
Nattokinase Encapsulated Nanomedicine for Targeted Thrombolysis: Development, Improved in Vivo Thrombolytic Effects, and Ultrasound/Photoacoustic Imaging. Molecular pharmaceutics (2023)
Aseem Setia, Abhishesh Kumar Mehata, Vishnu Priya, Datta Maroti Pawde, Dharmendra Jain, Sanjeev Kumar Mahto, Madaswamy S Muthu
Current Advances in Nanotheranostics for Molecular Imaging and Therapy of Cardiovascular Disorders. Molecular pharmaceutics (2023)
Piyush Dhamija, Abhishesh Kumar Mehata, Aseem Setia, Vishnu Priya, Ankit Kumar Malik, Jyoti Bonlawar, Nidhi Verma, Paresh Badgujar, Nandini Randhave, Madaswamy S Muthu
Nanotheranostics: Molecular Diagnostics and Nanotherapeutic Evaluation by Photoacoustic/Ultrasound Imaging in Small Animals. Molecular pharmaceutics (2023)
Abhishesh Kumar Mehata, Niharika Gupta, Madaswamy S Muthu
Exosomes as a novel nanomedicine platform for personalized triple-negative breast cancer therapy. Nanomedicine (London, England) (2023)
null Vikas, Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Ankit Kumar Malik, Aseem Setia, Pooja Kumari, Sanjeev Kumar Mahto, Madaswamy S Muthu
EGFR Targeted Redox Sensitive Chitosan Nanoparticles of Cabazitaxel: Dual-Targeted Cancer Therapy, Lung Distribution, and Targeting Studies by Photoacoustic and Optical Imaging. Biomacromolecules (2023)
Vishnu Priya, null Samridhi, Nitesh Singh, Debabrata Dash, Madaswamy S Muthu
Nattokinase Encapsulated Nanomedicine for Targeted Thrombolysis: Development, Improved in Vivo Thrombolytic Effects, and Ultrasound/Photoacoustic Imaging. Molecular pharmaceutics 21 (1) (2023)
Saurabh Shekhar, Mahima Chauhan, Sonali, Bhavna Yadav, Rohit Dutt, Liandong Hu, Madaswamy S Muthu, Rahul Pratap Singh
Enhanced permeability and retention effect-focused tumor-targeted nanomedicines: latest trends, obstacles and future perspective. Nanomedicine (London, England) 17 (18) (2022)
Vishnu Priya, Sanjeev K Singh, Ravindran Revand, Sandip Kumar, Abhishesh Kumar Mehata, Paulraj Sushmitha, Sanjeev Kumar Mahto, Madaswamy S Muthu
GPIIb/IIIa Receptor Targeted Rutin Loaded Liposomes for Site-Specific Antithrombotic Effect. Molecular pharmaceutics (2022)
null Vikas, Hemendra Kumar Sahu, Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, Madaswamy S Muthu
Dual-receptor-targeted nanomedicines: emerging trends and advances in lung cancer therapeutics. Nanomedicine (London, England) 17 (19) (2022)
Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, null Vikas, Madaswamy S Muthu
Harnessing immunological targets for COVID-19 immunotherapy. Future virology (2021)
Vishnu Priya, Matte Kasi Viswanadh, Abhishesh Kumar Mehata, Dharmendra Jain, Sanjeev K Singh, Madaswamy S Muthu
Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis. Nanomedicine (London, England) 16 (13) (2021)
null Narendra, Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Roshan Sonkar, Datta Maroti Pawde, Vishnu Priya, Mamata Singh, Biplob Koch, Madaswamy S Muthu
Formulation and in vitro evaluation of upconversion nanoparticle-loaded liposomes for brain cancer. Therapeutic delivery 11 (9) (2020)
Matte Kasi Viswanadh, null Vikas, Abhishek Jha, Sandeep Kumar Reddy Adena, Abhishesh Kumar Mehata, Vishnu Priya, Kaushik Neogi, Suruchi Poddar, Sanjeev Kumar Mahto, Madaswamy S Muthu
Formulation and in vivo efficacy study of cetuximab decorated targeted bioadhesive nanomedicine for non-small-cell lung cancer therapy. Nanomedicine (London, England) 15 (24) (2020)